A Study to Evaluate the Safety, Tolerability, PK and PD of HNC364 Injectable Suspension
Status:
Recruiting
Trial end date:
2023-04-05
Target enrollment:
Participant gender:
Summary
This is a non-randomized, dose-escalation first-in-human study to evaluate the safety,
tolerability, PK, and PD of HNC364 following intramuscular administration of single ascending
doses.